Tetraphase Pharmaceuticals, Inc.

Q4 2016 vs. Q1 2023 13F Holders

Period
Q4 2016
Q1 2023
Num holders
97
1
Total reported value, excl. options
$73.2 M
$0
Total shares, excl. options
18,162,746
1
Manager Q4 2016
Shares
Q1 2023
Shares
Diff Chg %